Todd Carter reports a stock award at Voyager Therapeutics
By AlphaYouPublished Form 4
Carter Todd Alfred
Reporting filer
Todd Alfred Carter reports a stock award, not an open-market purchase or sale, in Voyager Therapeutics, Inc.. Form 4 filed Nov 3, 2026 lists 2 entries.
- Disclosed
- Nov 3, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Carter Todd Alfred | 2026-11-01 | A | Grant or award | 33000 | 0.00 | 178,718 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Carter Todd Alfred | 2026-11-01 | A | Grant or award | 154000 | 0.00 | 154,000 | 2 days | Filed terms
|
Common Stock
- Owner
- Carter Todd Alfred
- Date
- 2026-11-01
- Code
- A
- Action
- Grant or award
- Quantity
- 33000
- Price
- 0.00
- Following holdings
- 178,718
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 33000
- id: F1
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 178718
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Carter Todd Alfred
- Date
- 2026-11-01
- Code
- A
- Action
- Grant or award
- Quantity
- 154000
- Price
- 0.00
- Following holdings
- 154,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 1.72
- transaction Date: 2026-11-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 154000
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-11-01
- underlying Security Title: Common Stock
- underlying Security Shares: 154000
- shares Owned Following Transaction: 154000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Carter Todd Alfred: Chief Scientific Officer.
- F1: Consists of shares of common stock issuable under an aggregate of 33,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, November 1, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service.
- F2: This stock option was issued pursuant to the Plan. The vesting commencement date of the option is October 20, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.
Original sources
Prepared automatically from public filing data. Report a correction.